BNP Paribas’s Bristol-Myers Squibb BMY Stock Holding History

BNP Paribas’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.93M	Buy	120,493 +1,992	+2%	+$114K	0.19%	79
2026 Q1	$7.2M	Buy	118,501 +39,456	+50%	+$2.3M	0.23%	77
2025 Q4	$4.26M	Buy	79,045 +42,960	+119%	+$2.07M	0.12%	102
2025 Q3	$1.63M	Sell	36,085 -27,033	-43%	-$1.26M	0.05%	136
2025 Q2	$2.92M	Buy	63,118 +22,262	+54%	+$1.09M	0.09%	114
2025 Q1	$2.65M	Buy	40,856 +26,494	+184%	+$1.54M	0.11%	109
2024 Q4	$1.93M	Sell	14,362 -25,101	-64%	-$1.4M	0.01%	120
2024 Q3	$2.03M	Buy	39,463 +28,453	+258%	+$1.33M	0.08%	103
2024 Q2	$457K	Sell	11,010 -16,291	-60%	-$729K	0.02%	193
2024 Q1	$1.48M	Buy	+27,301	New	+$1.39M	0.07%	123

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BNP Paribas's BMY Position: Q2 2026 in Review

BNP Paribas increased its Bristol-Myers Squibb (BMY) stake by 1.7% in Q2 2026, buying an estimated $114K and bringing the position to 120,493 shares worth $6.93M. The position accounts for 0.19% of the portfolio, ranked #79.

BNP Paribas first reported a position in BMY in Q1 2024 and has held it in 10 quarters since. The position peaked at $7.2M in Q1 2026. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

BNP Paribas held 120,493 shares of Bristol-Myers Squibb worth $6.93M as of Q2 2026.
BNP Paribas bought 1,992 Bristol-Myers Squibb shares in Q2 2026, an estimated $114K.
Bristol-Myers Squibb made up 0.19% of BNP Paribas's portfolio in Q2 2026, its #79 holding.
BNP Paribas first reported a position in Bristol-Myers Squibb in Q1 2024 and has held it in 10 quarters since.
BNP Paribas's Bristol-Myers Squibb position peaked at $7.2M in Q1 2026.
2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on BNP Paribas's 13F filing for Q2 2026, filed 13 Aug 2026.